Palliative care in interstitial lung disease: living well

The Lancet Respiratory Medicine

Volumn 5, Issue 12, 2017, Pages 968-980

  Kreuter, Michael ^a   Bendstrup, Elisabeth ^b   Russell, Anne Marie ^c   Bajwah, Sabrina ^d   Lindell, Kathleen ^e   Adir, Yochai ^f   Brown, Crystal E ^g,h   Calligaro, Greg ⁱ   Cassidy, Nicola ^j   Corte, Tamera J ^k   Geissler, Klaus ^l   Hassan, Azza Adel ^m,n   Johannson, Kerri A ^o   Kairalla, Ronaldo ^p   Kolb, Martin ^q   Kondoh, Yasuhiro ^r   Quadrelli, Sylvia ^s   Swigris, Jeff ^t   Udwadia, Zarir ^u   Wells, Athol ^c,v   Wijsenbeek, Marlies ^w   more..

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f CARMEL MEDICAL CENTER   (Israel)

^g UNIVERSITY OF WASHINGTON   (United States)

^h UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CAPE TOWN   (South Africa)

^j Irish Lung Fibrosis Association   (Ireland)

^k ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^l Lungenfibrose eV   (Germany)

^m HAMAD MEDICAL CORPORATION   (Qatar)

ⁿ ALEXANDRIA UNIVERSITY   (Egypt)

^o UNIVERSITY OF CALGARY   (Canada)

^p UNIVERSITY OF SÃO PAULO   (Brazil)

^q MCMASTER UNIVERSITY   (Canada)

^r NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^s HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^t DEPARTMENT OF MEDICINE   (United States)

^u P D HINDUJA NATIONAL HOSPITAL   (India)

^v ROYAL BROMPTON HOSPITAL   (United Kingdom)

^w ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BEREAVEMENT SUPPORT; CAREGIVER; CLINICAL EFFECTIVENESS; CULTURAL FACTOR; DISEASE COURSE; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; INTERSTITIAL LUNG DISEASE; INTERVENTION STUDY; MEDICAL DECISION MAKING; PALLIATIVE THERAPY; PATIENT CARE; PATIENT PREFERENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RELIGION; REVIEW; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; ATTITUDE TO HEALTH; CHRONIC DISEASE; DISEASE EXACERBATION; HEALTH SERVICE; MORTALITY; PSYCHOLOGY; STANDARDS;

CAREGIVERS; CHRONIC DISEASE; DISEASE PROGRESSION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LUNG DISEASES, INTERSTITIAL; PALLIATIVE CARE; QUALITY OF LIFE;

EID: 85031323572     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(17)30383-1     Document Type: Review

References (126)

1. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (2016), 1459–1544.
2. Raghu, G, Collard, HR, Egan, JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183 (2011), 788–824.
3. Bajwah, S, Higginson, IJ, Ross, JR, et al. The palliative care needs for fibrotic interstitial lung disease: a qualitative study of patients, informal caregivers and health professionals. Palliat Med 27 (2013), 869–876.
4. Bonella, F, Wijsenbeek, M, Molina-Molina, M, et al. European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers. Eur Respir J 47 (2016), 597–606.
5. Dalal, S, Palla, S, Hui, D, et al. Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. Oncologist 16 (2011), 105–111.
6. Morstad Boldt, A, Yusuf, F, Himelstein, BP, Perceptions of the term palliative care. J Palliat Med 9 (2006), 1128–1136.
7. Maciasz, RM, Arnold, RM, Chu, E, et al. Does it matter what you call it? A randomized trial of language used to describe palliative care services. Support Care Cancer 21 (2013), 3411–3419.
8. KO, Lindell, SUPPORT. Pittsburgh, PA: University of Pittsburg, 2017.
9. Lee, JS, McLaughlin, S, Collard, HR, Comprehensive care of the patient with idiopathic pulmonary fibrosis. Curr Opin Pulm Med 17 (2011), 348–354.
10. Zimmermann, C, Swami, N, Krzyzanowska, M, et al. Perceptions of palliative care among patients with advanced cancer and their caregivers. CMAJ 188 (2016), E217–E227.
11. McIlfatrick, S, Noble, H, McCorry, NK, et al. Exploring public awareness and perceptions of palliative care: a qualitative study. Palliat Med 28 (2014), 273–280.
12. Zimmermann, C, Rodin, G, The denial of death thesis: sociological critique and implications for palliative care. Palliat Med 18 (2004), 273–280.
13. Fadul, N, Elsayem, A, Palmer, JL, et al. Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center. Cancer 115 (2009), 2013–2021.
14. LeBlanc, TW, O'Donnell, JD, Crowley-Matoka, M, et al. Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study. J Oncol Pract 11 (2015), e230–e238.
15. Hanratty, B, Hibbert, D, Mair, F, et al. Doctors' understanding of palliative care. Palliat Med 20 (2006), 493–497.
16. Weil, J, Weiland, TJ, Lane, H, et al. What's in a name? A qualitative exploration of what is understood by “palliative care” in the emergency department. Palliat Med 29 (2015), 293–301.
17. Wentlandt, K, Krzyzanowska, MK, Swami, N, Rodin, GM, Le, LW, Zimmermann, C, Referral practices of oncologists to specialized palliative care. J Clin Oncol 30 (2012), 4380–4386.
18. Hui, D, Kim, SH, Kwon, JH, et al. Access to palliative care among patients treated at a comprehensive cancer center. Oncologist 17 (2012), 1574–1580.
19. Lindell, KO, Liang, Z, Hoffman, LA, et al. Palliative care and location of death in decedents with idiopathic pulmonary fibrosis. Chest 147 (2015), 423–429.
20. Lindell, KO, Kavalieratos, D, Gibson, KF, Tycon, L, Rosenzweig, M, The palliative care needs of patients with idiopathic pulmonary fibrosis: A qualitative study of patients and family caregivers. Heart Lung 46 (2017), 24–29.
21. WHO. WHO definition of palliative care. http://www.who.int/cancer/palliative/definition/en/ (accessed June 1, 2017).
22. IMPACT IMPACT, EURO. European Declaration on Palliative Care, 2014 http://palliativecare2020.eu/declaration/ (accessed June 1, 2017).
23. Kreuter, M, Swigris, J, Pittrow, D, et al. Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry. Respir Res, 18, 2017, 139.
24. Yount, SE, Beaumont, JL, Chen, SY, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. Lung 194 (2016), 227–234.
25. Overgaard, D, Kaldan, G, Marsaa, K, Nielsen, TL, Shaker, SB, Egerod, I, The lived experience with idiopathic pulmonary fibrosis: a qualitative study. Eur Respir J 47 (2016), 1472–1480.
26. van Manen, MJ, Kreuter, M, van den Blink, B, et al. What patients with pulmonary fibrosis and their partners think: a live, educative survey in the Netherlands and Germany. ERJ Open Res 3 (2017), 00065–02016.
27. CDER FDA, The voice of the patient: a series of reports from the U.S. Food and Drug Administration's (FDA's) patient-focused drug development initiative. Idiopathic pulmonary fibrosis. Silver Spring, MD: U.S Food and Drug Administration. https://www.fda.gov/downloads/ForIndustry/UserFees/PrescriptionDrugUserFee/UCM440829.pdf (accessed June 1, 2017).
28. Garibaldi, BT, Danoff, SK, Symptom-based management of the idiopathic interstitial pneumonia. Respirology 21 (2016), 1357–1365.
29. Glaspole, IN, Chapman, SA, Cooper, WA, et al. Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry. Respirology 22 (2017), 950–956.
30. Matsunuma, R, Takato, H, Takeda, Y, et al. Patients with end-stage interstitial lung disease may have more problems with dyspnea than end-stage lung cancer patients. Indian J Palliat Care 22 (2016), 282–287.
31. Ahmadi, Z, Wysham, NG, Lundstrom, S, Janson, C, Currow, DC, Ekstrom, M, End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study. Thorax 71 (2016), 510–516.
32. Richeldi, L, du Bois, RM, Raghu, G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370 (2014), 2071–2082.
33. King, TE Jr, Bradford, WZ, Castro-Bernardini, S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370 (2014), 2083–2092.
34. Belkin, A, Albright, K, Swigris, JJ, A qualitative study of informal caregivers' perspectives on the effects of idiopathic pulmonary fibrosis. BMJ Open Respir Res, 1, 2014, e000007.
35. Duck, A, Spencer, LG, Bailey, S, Leonard, C, Ormes, J, Caress, AL, Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis. J Adv Nurs 71 (2015), 1055–1065.
36. Thickett, DR, Kendall, C, Spencer, LG, et al. Improving care for patients with idiopathic pulmonary fibrosis (IPF) in the UK: a round table discussion. Thorax 69 (2014), 1136–1140.
37. Russell, AM, Ripamonti, E, Vancheri, C, Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients' perspectives of the disease and treatment. BMC Pulm Med, 16, 2016, 10.
38. Sampson, C, Gill, BH, Harrison, NK, Nelson, A, Byrne, A, The care needs of patients with idiopathic pulmonary fibrosis and their carers (CaNoPy): results of a qualitative study. BMC Pulm Med, 15, 2015, 155.
39. Schoenheit, G, Becattelli, I, Cohen, AH, Living with idiopathic pulmonary fibrosis: an in-depth qualitative survey of European patients. Chron Respir Dis 8 (2011), 225–231.
40. Bajwah, S, Koffman, J, Higginson, IJ, et al. ‘I wish I knew more.’ the end-of-life planning and information needs for end-stage fibrotic interstitial lung disease: views of patients, carers and health professionals. BMJ Support Palliat Care 3 (2013), 84–90.
41. Collard, HR, Tino, G, Noble, PW, et al. Patient experiences with pulmonary fibrosis. Respir Med 101 (2007), 1350–1354.
42. Bridges, JF, Paly, VF, Barker, E, Kervitsky, D, Identifying the benefits and risks of emerging treatments for idiopathic pulmonary fibrosis: a qualitative study. Patient 8 (2015), 85–92.
43. Higginson, IJ, Addington-Hall, JM, Palliative care needs to be provided on basis of need rather than diagnosis. BMJ, 318, 1999, 123.
44. Murtagh, FE, Bausewein, C, Verne, J, Groeneveld, EI, Kaloki, YE, Higginson, IJ, How many people need palliative care? A study developing and comparing methods for population-based estimates. Palliat Med 28 (2014), 49–58.
45. Waller, A, Girgis, A, Johnson, C, et al. Facilitating needs based cancer care for people with a chronic disease: evaluation of an intervention using a multi-centre interrupted time series design. BMC Palliat Care, 9, 2010, 2.
46. van Manen, MJ, Geelhoed, JJ, Tak, NC, Wijsenbeek, MS, Optimizing quality of life in patients with idiopathic pulmonary fibrosis. Ther Adv Respir Dis 11 (2017), 157–169.
47. Sharp, C, Lamb, H, Jordan, N, et al. Development of tools to facilitate palliative and supportive care referral for patients with idiopathic pulmonary fibrosis. BMJ Support Palliat Care, 2017 10.1136/bmjspcare-2017-001330 published online June 30.
48. Boland, JW, Reigada, C, Yorke, J, et al. The adaptation, face, and content validation of a needs assessment tool: progressive disease for people with interstitial lung disease. J Palliat Med 19 (2016), 549–555.
49. Matsuda, T, Taniguchi, H, Ando, M, et al. COPD Assessment Test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross-sectional study. Respirology 22 (2017), 721–727.
50. Bajwah, S, Ross, JR, Wells, AU, et al. Palliative care for patients with advanced fibrotic lung disease: a randomised controlled phase II and feasibility trial of a community case conference intervention. Thorax 70 (2015), 830–839.
51. Wuyts, WA, Peccatori, FA, Russell, AM, Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models. Eur Respir Rev 23 (2014), 231–238.
52. Wijsenbeek, M, Bendstrup, E, Ross, J, Wells, A, Cultural Differences in Palliative Care in Patients With Idiopathic Pulmonary Fibrosis. Chest, 148, 2015, e56.
53. Liang, Z, Hoffman, LA, Nouraie, M, et al. Referral to palliative care infrequent in patients with idiopathic pulmonary fibrosis admitted to an intensive care unit. J Palliat Med 20 (2017), 134–140.
54. Pleschberger, S, Wosko, P, From neighbour to carer: an exploratory study on the role of non-kin-carers in end-of-life care at home for older people living alone. Palliat Med 31 (2017), 559–565.
55. Burton, AM, Sautter, JM, Tulsky, JA, et al. Burden and well-being among a diverse sample of cancer, congestive heart failure, and chronic obstructive pulmonary disease caregivers. J Pain Symptom Manage 44 (2012), 410–420.
56. Burton, AM, Haley, WE, Small, BJ, Finley, MR, Dillinger-Vasille, M, Schonwetter, R, Predictors of well-being in bereaved former hospice caregivers: the role of caregiving stressors, appraisals, and social resources. Palliat Support Care 6 (2008), 149–158.
57. Cutrino, A, Santamaria, J, Research on family caregivers: understanding levels of burden and how to provide assistance. Home Healthc Nurse 31 (2013), 331–337.
58. Bajwah, S, Ross, JR, Peacock, JL, et al. Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature. Thorax 68 (2013), 867–879.
59. Kohberg, C, Andersen, CU, Bendstrup, E, Opioids: an unexplored option for treatment of dyspnea in IPF. Eur Clin Respir J, 3, 2016, 30629.
60. Currow, DC, McDonald, C, Oaten, S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage 42 (2011), 388–399.
61. Simon, ST, Higginson, IJ, Booth, S, Harding, R, Bausewein, C, Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev, 1, 2010, CD007354.
62. Birks, C, Pathophysiology and the management of dyspnea in palliative care and the evolving role of the nurse. Int J Palliat Nurs 3 (1997), 264–274.
63. Booth, S, Wade, R, Johnson, M, Kite, S, Swannick, M, Anderson, H, The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med 98 (2004), 66–77.
64. Crockett, A, Cranston, JM, Antic, N, Domiciliary oxygen for interstitial lung disease. Cochrane Database Syst Rev, 3, 2001, CD002883.
65. Zielinski, J, Long-term oxygen therapy in conditions other than chronic obstructive pulmonary disease. Respir Care 45 (2000), 172–176.
66. Nishiyama, O, Miyajima, H, Fukai, Y, et al. Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia. Respir Med 107 (2013), 1241–1246.
67. Luckett, T, Phillips, J, Johnson, MJ, et al. Contributions of a hand-held fan to self-management of chronic breathlessness. Eur Respir J, 50, 2017, 1700262.
68. Dowman, L, Hill, CJ, Holland, AE, Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev, 10, 2014, CD006322.
69. Ours, TM, Kavuru, MS, Schilz, RJ, Richter, JE, A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 94 (1999), 3131–3138.
70. Homsi, J, Walsh, D, Nelson, KA, Important drugs for cough in advanced cancer. Support Care Cancer 9 (2001), 565–574.
71. Morice, AH, Menon, MS, Mulrennan, SA, et al. Opiate therapy in chronic cough. Am J Respir Crit Care Med 175 (2007), 312–315.
72. Fuller, RW, Karlsson, JA, Choudry, NB, Pride, NB, Effect of inhaled and systemic opiates on responses to inhaled capsaicin in humans. J Appl Physiol (1985) 65 (1988), 1125–1130.
73. Mintz, S, Lee, JK, Gabapentin in the treatment of intractable idiopathic chronic cough: case reports. Am J Med 119 (2006), e13–e15.
74. Hope-Gill, BD, Hilldrup, S, Davies, C, Newton, RP, Harrison, NK, A study of the cough reflex in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168 (2003), 995–1002.
75. Morice, AH, McGarvey, L, Pavord, I, on behalf of the British Thoracic Society Cough Guideline Group. Recommendations for the management of cough in adults. Thorax 61:suppl 1 (2006), i1–24.
76. Irwin, RS, Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest 129:1 suppl (2006), 80–94S.
77. Kiljander, TO, Salomaa, ER, Hietanen, EK, Terho, EO, Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J 16 (2000), 633–638.
78. Poe, RH, Kallay, MC, Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 123 (2003), 679–684.
79. Rayner, L, Higginson, I, Price, A, Hoptof, M, The management of depression in palliative care: draft European clinical guidelines, 2009, King's College London, London.
80. Van Manen M, SS Birring, C Vancheri, Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis. Eur Res J, (in press).
81. Holland, AE, Exercise limitation in interstitial lung disease—mechanisms, significance and therapeutic options. Chron Respir Dis 7 (2010), 101–111.
82. Bell, EC, Cox, NS, Goh, N, et al. Oxygen therapy for interstitial lung disease: a systematic review. Eur Respir Rev, 26, 2017, 160080.
83. Visca, D, Mori, L, Tsipouri, V, et al. AmbOx: a randomised controlled, crossover trial evaluating the effects of ambulatory oxygen on health status in patients with fibrotic interstitial lung disease. Am J Respir Crit Care Med, 195, 2017, A7603 (abstr).
84. Bajwah, S, Higginson, IJ, Ross, JR, et al. Specialist palliative care is more than drugs: a retrospective study of ILD patients. Lung 190 (2012), 215–220.
85. Dowman, LM, McDonald, CF, Hill, CJ, et al. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Thorax 72 (2017), 610–619.
86. Wei, W, Liu, R, ZhangTong, Y, Qiu, Z, The efficacy of specific neuromodulators on human refractory chronic cough: a systematic review and meta-analysis. J Thorac Dis 8 (2016), 2942–2951.
87. Horton, MR, Santopietro, V, Mathew, L, et al. Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial. Ann Intern Med 157 (2012), 398–406.
88. Birring, SS, Wijsenbeek, MS, Agrawal, S, et al. A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial. Lancet Respir Med 5 (2017), 806–815.
89. Idiopathic Pulmonary Fibrosis Clinical Research Network, Zisman, DA, Schwarz, M, et al. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med 363 (2010), 620–628.
90. van Manen, MJG, van ‘t Spijker, A, Tak, NC, et al. Patient and partner empowerment programme for idiopathic pulmonary fibrosis. Eur Respir J, 49, 2017, 1601596.
91. Kellehear, A, Spirituality and palliative care: a model of needs. Palliat Med 14 (2000), 149–155.
92. Engelhardt, HT Jr, Iltis, AS, End-of-life: the traditional Christian view. Lancet 366 (2005), 1045–1049.
93. Riolfi, M, Buja, A, Zanardo, C, Marangon, CF, Manno, P, Baldo, V, Effectiveness of palliative home-care services in reducing hospital admissions and determinants of hospitalization for terminally ill patients followed up by a palliative home-care team: a retrospective cohort study. Palliat Med 28 (2014), 403–411.
94. Skorstengaard, MH, Neergaard, MA, Andreassen, P, et al. Preferred place of care and death in terminally ill patients with lung and heart disease compared to cancer patients. J Palliat Med, 2017 10.1089/jpm.2017.0082 published online June 2. DOI.
95. Rajala, K, Lehto, JT, Saarinen, M, Sutinen, E, Saarto, T, Myllarniemi, M, End-of-life care of patients with idiopathic pulmonary fibrosis. BMC Palliat Care, 15, 2016, 85.
96. Temel, JS, Greer, JA, Muzikansky, A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363 (2010), 733–742.
97. Guldin, MB, Vedsted, P, Jensen, AB, Olesen, F, Zachariae, R, Bereavement care in general practice: a cluster-randomized clinical trial. Fam Pract 30 (2013), 134–141.
98. Hyldgaard, C, Hilberg, O, Bendstrup, E, How does comorbidity influence survival in idiopathic pulmonary fibrosis?. Respir Med 108 (2014), 647–653.
99. Raghu, G, Amatto, VC, Behr, J, Stowasser, S, Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J 46 (2015), 1113–1130.
100. Kreuter, M, Ehlers-Tenenbaum, S, Palmowski, K, et al. Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis. PLoS One, 11, 2016, e0151425.
101. Sinclair, C, Auret, KA, Evans, SF, et al. Advance care planning uptake among patients with severe lung disease: a randomised patient preference trial of a nurse-led, facilitated advance care planning intervention. BMJ Open, 7, 2017, e013415.
102. NICE. End of life care for adults, March, 2017 https://www.nice.org.uk/guidance/qs13/resources (accessed June 1, 2017).
103. Bulow, HH, Sprung, CL, Reinhart, K, et al. The world's major religions' points of view on end-of-life decisions in the intensive care unit. Intensive Care Med 34 (2008), 423–430.
104. Giot, C, Maronati, M, Becattelli, I, Schoenheit, G, Idiopathic pulmonary fibrosis: an EU patient perspective survey. Curr Respir Med Rev 9 (2013), 112–119.
105. Higginson, IJ, Rumble, C, Shipman, C, et al. The value of uncertainty in critical illness? An ethnographic study of patterns and conflicts in care and decision-making trajectories. BMC Anesthesiol, 16, 2016, 11.
106. Mallick, S, Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit. Respir Med 102 (2008), 1355–1359.
107. Collard, HR, Ryerson, CJ, Corte, TJ, et al. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. Am J Respir Crit Care Med 194 (2016), 265–275.
108. Natsuizaka, M, Chiba, H, Kuronuma, K, et al. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med 190 (2014), 773–779.
109. Rush, B, Wiskar, K, Berger, L, Griesdale, D, The use of mechanical ventilation in patients with idiopathic pulmonary fibrosis in the United States: A nationwide retrospective cohort analysis. Respir Med 111 (2016), 72–76.
110. Oda, K, Yatera, K, Fujino, Y, et al. Efficacy of concurrent treatments in idiopathic pulmonary fibrosis patients with a rapid progression of respiratory failure: an analysis of a national administrative database in Japan. BMC Pulm Med, 16, 2016, 91.
111. Higginson, IJ, Bausewein, C, Reilly, CC, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med 2 (2014), 979–987.
112. Bakitas, MA, Tosteson, TD, Li, Z, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 33 (2015), 1438–1445.
113. Dionne-Odom, JN, Azuero, A, Lyons, KD, et al. Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: outcomes from the ENABLE III randomized controlled trial. J Clin Oncol 33 (2015), 1446–1452.
114. Higginson, IJ, Finlay, IG, Goodwin, DM, et al. Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers?. J Pain Symptom Manage 25 (2003), 150–168.
115. Douglas, HR, Normand, CE, Higginson, IJ, Goodwin, DM, Myers, K, Palliative Day Care Project Group. Palliative day care: what does it cost to run a centre and does attendance affect use of other services?. Palliat Med 17 (2003), 628–637.
116. Lanken, PN, Terry, PB, Delisser, HM, et al. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med 177 (2008), 912–927.
117. Bruera, E, Kuehn, N, Miller, MJ, Selmser, P, Macmillan, K, The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7 (1991), 6–9.
118. Hui, D, Titus, A, Curtis, T, et al. Implementation of the Edmonton Symptom Assessment System for symptom distress screening at a community cancer center: a pilot program. Oncologist 22 (2017), 995–1001.
119. Hearn, J, Higginson, IJ, Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group. Qual Health Care 8 (1999), 219–227.
120. Brereton, L, Clark, J, Ingleton, C, et al. What do we know about different models of providing palliative care? Findings from a systematic review of reviews. Palliat Med 31 (2017), 781–797.
121. Dzingina, MD, McCrone, P, Higginson, IJ, Does the EQ-5D capture the concerns measured by the Palliative care Outcome Scale? Mapping the Palliative care Outcome Scale onto the EQ-5D using statistical methods. Palliat Med 31 (2017), 716–725.
122. Udwadia, ZF, Richeldi, L, Interstitial Lung Disease in India. Keep searching and you'll keep finding. Am J Respir Crit Care Med 195 (2017), 714–715.
123. McDermott, E, Selman, L, Wright, M, Clark, D, Hospice and palliative care development in India: a multimethod review of services and experiences. J Pain Symptom Manage 35 (2008), 583–593.
124. Khosla, D, Patel, FD, Sharma, SC, Palliative care in India: current progress and future needs. Indian J Palliat Care 18 (2012), 149–154.
125. Fischer, A, Antoniou, KM, Brown, KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. “ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD”. Eur Respir J 46 (2015), 976–978.
126. Saketkoo, LA, Mittoo, S, Huscher, D, et al. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials. Thorax 69 (2014), 428–436.